Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Facing Possible Cuts – Or The Opposite – In FY 2014 Budget, Hamburg Says

This article was originally published in The Gray Sheet

Executive Summary

Commissioner tells FDA Science Board that both cuts and additions are on the table as early planning gets under way for the fiscal year that begins in October 2013.

Advertisement

Related Content

Senate Panel Approves FDA Appropriations, With Strong Words On Agency IT Systems
$10 Million Needed For Inspections In China, FDA Commissioner Tells Congress
FDA Appropriators Discuss Ending The Food & Drug Administration
User Fee Factor: FDA Relies On Industry Funds To Bankroll 2013 Device Budget Increase
FDA Reaps $49 Million Increase For 2012 Despite Budget-Cutting Mentality
Advertisement
UsernamePublicRestriction

Register

MT031197

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel